AGYS
Agilysys, Inc.
AGYS's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over AGYS overall, supported by stronger modeled upside and stronger valuation.
AGYS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
AGYS's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
AGYS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 34x | $52.61 | -57% |
| Forward | 42x | $122 | — |
| Current | 77x | $122 | — |
| Fair | 133x | $209 | +72% |
| Expensive | 214x | $336 | +176% |
Historical ranges are pointers, not guarantees.
AGYS's PE is in its fair range at 77x. If earnings grow as analysts expect, today's price would be 42x next year's earnings, in its cheap range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over AGYS in the historical PE scenario, which offers more potential upside but is not a forecast.
AGYS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
AGYS has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
AGYS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.91 | +85% |
| Q3 2026 | $1.57 | +85% |
| Q2 2026 | $1.52 | +210% |
| Q1 2026 | $1.37 | +67% |
| Q4 2025 | $1.06 | +31% |
| Q3 2025 | $0.85 | -76% |
| Q2 2025 | $0.49 | -87% |
| Q1 2025 | $0.82 | -74% |
| Q4 2024 | $0.81 | -75% |
AGYS's earnings per share have fallen from their peak: $1.57 over the past year, against $3.63 in mid-2024.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over AGYS on earnings, with more consistent year-over-year improvement.
AGYS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $93.4M | +18% |
| Q2 2026 | $87.7M | +14% |
| Q1 2026 | $82.9M | +12% |
| Q4 2025 | $80.4M | +16% |
| Q3 2025 | $79.3M | +16% |
| Q2 2025 | $76.7M | +21% |
| Q1 2025 | $74.3M | +19% |
| Q4 2024 | $69.6M | +15% |
AGYS's revenue has grown year over year for 22 quarters in a row: $93M last quarter, up 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.5 points |
| Q2 2026 | 11% | +5.2 points |
| Q1 2026 | 15% | +8.1 points |
| Q4 2025 | 15% | +3.9 points |
| Q3 2025 | 18% | +12 points |
| Q2 2025 | 5.9% | -3.2 points |
| Q1 2025 | 7.2% | +1.6 points |
| Q4 2024 | 11% | -2.2 points |
AGYS's operating margin was 16% last quarter, down 1.5 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over AGYS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over AGYS on profitability, with a higher operating margin.
AGYS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.8M | -1.2% |
| Q2 2026 | $7.3M | +$12.3M |
| Q1 2026 | $35.4M | +34% |
| Q4 2025 | $22.7M | +15% |
| Q3 2025 | $15M | +153% |
| Q2 2025 | -$5M | -2274% |
| Q1 2025 | $26.5M | -9.8% |
| Q4 2024 | $19.7M | +75% |
AGYS generated $80M in free cash flow over the past year, up 43% from the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over AGYS on cash flow, with more consistent year-over-year improvement.
AGYS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +157K shares |
| 1 year | +0.6% | +180K shares |
| 3 years | +9.4% | +2.5M shares |
| 5 years | +12% | +3.2M shares |
| Available history | +23% | +5.3M shares |
AGYS has 29M diluted shares, up 0.6% from a year ago.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over AGYS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
AGYS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.4x | Net Cash |
| Q2 2026 | -2.2x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -1.8x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
AGYS has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AGYS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 79.9 | Neutral |
AGYS's weekly RSI is 63 (neutral) and its Stochastic is 80 (neutral).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
AGYS PE vs Technology Sector
| Metric | AGYS | Sector median | Relative |
|---|---|---|---|
| PE | 77x | 28x | 178% above |
| PE % | 37 | 35 | 2 pts above |
AGYS is trading at 77x earnings, a 178% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over AGYS on valuation relative to its sector.
AGYS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $111.6 | 8.9% above |
| 20 week MA | $109.7 | 11% above |
| 50 week MA | $96.9 | 25% above |
| 100 week MA | $99.9 | 22% above |
| 200 week MA | $93.9 | 29% above |
AGYS has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
AGYS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $25.5 | $41.0 | +61% |
| 2021 | $41.0 | $44.4 | +8.3% |
| 2022 | $44.4 | $80.1 | +80% |
| 2023 | $80.1 | $84.8 | +5.9% |
| 2024 | $84.8 | $135.6 | +60% |
| 2025 | $135.6 | $121.5 | -10% |
| 2026 YTD | $121.5 | $121.6 | +0.1% |
AGYS has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.